Science Explorer Back to mapMap
Discussion
Institution · Psychogenics (United States)

Most cited papers from Psychogenics (United States)

Psychogenics (United States)

What are the most cited papers from Psychogenics (United States)?

The most cited paper from Psychogenics (United States) is "Neuregulin 1 and Susceptibility to Schizophrenia" (Hreinn Stefánsson et al., 2002), with 1,697 citations. Next come "Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features" (633) and "Comprehensive Behavioral and Molecular Characterization of a New Knock-In Mouse Model of Huntington’s Disease: zQ175" (536).

Showing 50 of 60 papers. Every paper with more than 70 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Neuregulin 1 and Susceptibility to Schizophrenia Hreinn Stefánsson et al. · The American Journal of Human Genetics Open access Oct 2002 1,697
2 Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features Sergey M. Kalachikov, Oleg Vadimovich Evgrafov, Barbara G. Ross et al. · Nature Genetics Open access 28 Jan 2002 633
3 Comprehensive Behavioral and Molecular Characterization of a New Knock-In Mouse Model of Huntington’s Disease: zQ175 Liliana Menalled, Andrea E. Kudwa, Sam Miller et al. · PLoS ONE Open access 20 Dec 2012 536
4 Antisense oligonucleotides increase Scn1a expression and reduce seizures and SUDEP incidence in a mouse model of Dravet syndrome Han Zhou, Chunling Chen, Anne Christiansen et al. · Science Translational Medicine Open access 26 Aug 2020 352
5 Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models Liliana Menalled, Bassem F. El‐Khodor, Mélissa Patry et al. · Neurobiology of Disease Open access 22 May 2009 337
6 Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders Kristine Roy, Joshua C. Murtie, Bassem F. El‐Khodor et al. · Proceedings of the National Academy of Sciences Open access 2 May 2007 316
7 Cerebrospinal Fluid and Serum Markers of Inflammation in Autism Andrew W. Zimmerman, Harumi Jyonouchi, Anne M. Comi et al. · Pediatric Neurology Sep 2005 301
8 The stress-induced hyperthermia paradigm as a physiological animal model for anxiety: A review of pharmacological and genetic studies in the mouse J. Adriaan Bouwknecht, Berend Olivier, Richard E. Paylor · Neuroscience & Biobehavioral Reviews 18 Apr 2006 295
9 Mice with Chronically Elevated Dopamine Exhibit Enhanced Motivation, but not Learning, for a Food Reward Barbara Cagniard, Peter D. Balsam, Daniela Brunner et al. · Neuropsychopharmacology 23 Nov 2005 288
10 Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease Kuldip D. Dave et al. · Neurobiology of Disease Open access 24 Jun 2014 235
11 Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes H. Carlo Maurer, Sam R. Holmstrom, Jing He et al. · Gut Open access 18 Jan 2019 230
12 A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors Mariano J. Alvarez et al. · Nature Genetics Open access 15 Jun 2018 230
13 Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington’s disease Bryan Zeitler et al. · Nature Medicine Jul 2019 224
14 Stress-induced hyperthermia and anxiety: pharmacological validation Berend Olivier, Theo J.J. Zethof, Tommy Pattij et al. · European Journal of Pharmacology Feb 2003 211
15 Human glia can both induce and rescue aspects of disease phenotype in Huntington disease Abdellatif Benraiss, Su Wang, Stephanie A. Herrlinger et al. · Nature Communications Open access 7 Jun 2016 205
16 SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D2 Receptor Mechanism of Action Nina Dedic, PHILIP G. JONES, Seth C. Hopkins et al. · Journal of Pharmacology and Experimental Therapeutics Open access Aug 2019 178
17 The role of epigenetic modifications in cardiovascular disease: A systematic review Taulant Muka, Fjorda Koromani, Eliana C. Portilla et al. · International Journal of Cardiology ReviewOpen access 19 Mar 2016 177
18 Attenuated Response to Stress and Novelty and Hypersensitivity to Seizures in 5-HT 4 Receptor Knock-Out Mice Valérie Compan, Ming‐Ming Zhou, Régis Grailhe et al. · Journal of Neuroscience Open access 14 Jan 2004 174
19 Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding study Per Svenningsson, Carl Rosenblad, Karolina Af Edholm Arvidsson et al. · Brain Open access 5 Feb 2015 163
20 Knock-in mouse models of Huntington’s disease Liliana Menalled · NeuroRx Open access 13 Jun 2005 152
21 Absence of 5-HT1B receptors is associated with impaired impulse control in male 5-HT1B knockout mice J Adriaan Bouwknecht, Theo H. Hijzen, Jan van der Gugten et al. · Biological Psychiatry Apr 2001 151
22 A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease Marianne R. Smith et al. · Human Molecular Genetics Open access 16 Jan 2014 149
23 SIRT1: Regulator of p53 Deacetylation J. T. Lee, Wei Gu · Genes & Cancer Open access Mar 2013 144
24 HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in rats Bin Zhang, Eric J. West, Ken C. Van et al. · Brain Research Open access 12 Jun 2008 135
25 Phosphodiesterase 10A Inhibition Improves Cortico-Basal Ganglia Function in Huntington’s Disease Models Vahri Beaumont et al. · Neuron Open access Dec 2016 123
26 SAHA Enhances Synaptic Function and Plasticity In Vitro but Has Limited Brain Availability In Vivo and Does Not Impact Cognition Jesse E. Hanson, Hank La, Emile G. Plise et al. · PLoS ONE Open access 26 Jul 2013 121
27 The Role of DNA Methylation and Histone Modifications in Neurodegenerative Diseases: A Systematic Review Kexin Wen, Jelena Milić, Bassem F. El‐Khodor et al. · PLoS ONE ReviewOpen access 14 Dec 2016 120
28 Comprehensive Analysis of the 16p11.2 Deletion and Null Cntnap2 Mouse Models of Autism Spectrum Disorder Daniela Brunner, Patricia Kabitzke, Dansha He et al. · PLoS ONE Open access 14 Aug 2015 119
29 The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics? Berend Olivier, Christina L. Leahy, Tanner Mullen et al. · Psychopharmacology 22 Jun 2001 114
30 5-HT3 receptor antagonists and anxiety; a preclinical and clinical review Berend Olivier, Ineke van Wijngaarden, Willem Soudijn · European Neuropsychopharmacology Open access Mar 2000 110
31 Placebo-controlled randomized clinical trial of fish oil’s impact on fatigue, quality of life, and disease activity in Systemic Lupus Erythematosus Cristina Arriens, Linda Susan Hynan, Robert Howard Lerman et al. · Nutrition Journal Open access 17 Aug 2015 105
32 Translational aspects of pharmacological research into anxiety disorders: The stress-induced hyperthermia (SIH) paradigm Christiaan H. Vinkers, Meg J.V. van Bogaert, Marianne Klanker et al. · European Journal of Pharmacology 19 Mar 2008 105
33 Identification of a battery of tests for drug candidate evaluation in the SMNΔ7 neonate model of spinal muscular atrophy Bassem F. El‐Khodor, Nicole M. Edgar, Angela Chen et al. · Experimental Neurology 21 Mar 2008 103
34 Male and female 5-HT1B receptor knockout mice have higher body weights than wildtypes J. Adriaan Bouwknecht, Jan van der Gugten, Theo H. Hijzen et al. · Physiology & Behavior Nov 2001 103
35 cAMP Response Element-Binding Protein Deficiency Allows for Increased Neurogenesis and a Rapid Onset of Antidepressant Response Tamar Gur, Alana C. Conti, Jessica Holden et al. · Journal of Neuroscience Open access 18 Jul 2007 102
36 Interval timing in genetically modified mice: a simple paradigm Fuat Balcı, Efstathios B. Papachristos, Charles Randy Gallistel et al. · Genes Brain & Behavior Open access 19 Jul 2007 95
37 Peptide therapeutics for CNS indications Paul McGonigle · Biochemical Pharmacology 26 Oct 2011 95
38 Measuring reinforcement learning and motivation constructs in experimental animals: Relevance to the negative symptoms of schizophrenia Athina Markou, John D. Salamone, Timothy J. Bussey et al. · Neuroscience & Biobehavioral Reviews Open access 28 Aug 2013 94
39 The 5-HT 1A receptor knockout mouse and anxiety B. Olivier, Tommy Pattij, S.J. Wood et al. · Behavioural Pharmacology Nov 2001 92
40 Vitamin C Compound Mixtures Prevent Ozone-Induced Oxidative Damage in Human Keratinocytes as Initial Assessment of Pollution Protection Giuseppe Valacchi, Claudia Sticozzi, Giuseppe Belmonte et al. · PLoS ONE Open access 13 Aug 2015 91
41 Oncogenic hijacking of the stress response machinery in T cell acute lymphoblastic leukemia Nikos Kourtis, Charalampos Lazaris, Kathryn Hockemeyer et al. · Nature Medicine Open access 19 Jul 2018 89
42 Structure-Based Design Leads to the Identification of Lithium Mimetics That Block Mania-like Effects in Rodents. Possible New GSK-3β Therapies for Bipolar Disorders Alan P. Kozikowski, Irina N. Gaisina, Hongbin Yuan et al. · Journal of the American Chemical Society 7 Jun 2007 89
43 Effect of a low glycemic index diet with soy protein and phytosterols on CVD risk factors in postmenopausal women Dan Lukaczer, J. Liska DeAnn, Robert Howard Lerman et al. · Nutrition Feb 2006 87
44 Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone Neil E. Paterson, Jennifer Ricciardi, Caitlin Wetzler et al. · Neuroscience Research 9 Oct 2010 85
45 Timing Deficits in Aging and Neuropathology Fuat Balcı, Warren H. Meck, Holly M Moore et al. · Humana Press eBooks Book chapter 4 Nov 2008 84
46 High-throughput analysis of behavior for drug discovery Vadim Alexandrov, Dani Brunner, Taleen Hanania et al. · European Journal of Pharmacology Open access 12 Jan 2015 83
47 Cognitive Training at a Young Age Attenuates Deficits in the zQ175 Mouse Model of HD Paul C. P. Curtin, Andrew M. Farrar, Stephen Oakeshott et al. · Frontiers in Behavioral Neuroscience Open access 11 Jan 2016 82
48 Animal models of Huntington's disease for translation to the clinic: Best practices Liliana Menalled, Daniela Brunner · Movement Disorders 12 Sep 2014 82
49 R6/2 Huntington's Disease Mice Develop Early and Progressive Abnormal Brain Metabolism and Seizures Efraín Cepeda-Prado, Susanna Popp, Usman Khan et al. · Journal of Neuroscience Open access 9 May 2012 82
50 Modern Approaches To Photoprotection Holly V. DeBuys, Stanley B. Levy, John C S Murray et al. · Dermatologic Clinics Oct 2000 81

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.